Immunotherapeutic applications of CpG-containing oligodeoxynucleotides

Drug News and Perspectives

Volumn 13, Issue 5, 2000, Pages 289-296

  Klinman, D M ^a   Ishii, K J ^a   Gursel, M ^a   Gursel, I ^a   Takeshita, S ^a   Takeshita, F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTINEOPLASTIC AGENT; DINUCLEOTIDE; OLIGODEOXYNUCLEOTIDE;

ALLERGY; ANTIBACTERIAL ACTIVITY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; CANCER; DRUG USE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION; NATURAL KILLER CELL; REVIEW; TREATMENT INDICATION;

EID: 0033802045     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Inhibition of virus multiplication by foreign nucleic acid
2. Interferon responses of chick embryo fibroblasts to nucleic acids and related compounds
3. Antitumor effect of nucleic acid fraction from bacteria
4. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity
5. Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances IFN production and natural killer activity
6. DNA from bacteria, but not vertebrates, induces interferons, activate NK cells and inhibits tumor growth
7. CpG motifs in bacterial DNA trigger direct B-cell activation
8. DNA methylation and its possible biological roles
9. Pervasive CpG suppression in animal mitochondrial genomes
10. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNg
11. Bacterial DNA induces murine interferon-gamma production by stimulation of IL-12 and tumor necrosis factor-alpha
12. Immunostimulatory DNA sequences function as T helper-I promoting adjuvants
13. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria
14. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
15. Immunostimulatory DNA: Sequence-dependent production of potentially harmful or useful cytokines
16. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
17. Activation of cutaneous dendritic cells by CpG containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
18. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species
19. Binding, uptake, and intracellular trafficking of phosphorothioate-modifled oligodeoxynucleotides
20. Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein
21. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
22. Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA
23. Heterologous protection against influenza by injection of DNA encoding a viral protein
24. Direct gene transfer into mouse muscle in vivo
25. Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice
26. Gene inoculation generates immune responses against human immunodeficiency virus type 1
27. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA
28. CpG motifs as immune adjuvants
29. Therapeutic applications of CpG-containing oligodeoxynucleotides
30. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
31. Contribution of CpG motifs to the immunogenicity of DNA vaccines
32. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
33. CpG oligodeoxynucleotides act as adjuvants that switch on T helper (Th1) immunity
34. Production of IFN gamma, IL-2, IL-4 and IL-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis
35. Neutralizing antibody to IL-4 induces systemic protection and TH1-associated immunity in murine candidiasis
36. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
37. CpG oligonucleotides can circumvent the TH2 polarization of neonatal responses to vaccines but fail to fully redirect Th2 responses established by neonatal priming
38. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice
39. Amplification of antibody production by phosphorothioate oligodeoxynucleotides
40. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice
41. Immunostimulatory DNA is a potent mucosal adjuvant
42. Developmental aspects of immunity
43. Studies of human cord blood dendritic cells: Evidence for functional immaturity
44. The ontogeny of antigen-specific T cells
45. Induction of neonatal tolerance by plasmid DNA vaccination of mice
46. Prevention of neonatal tolerance by a plasmid encoding GM-CSF
47. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants
48. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
49. Requirement for IL-13 independently of IL-4 in experimental asthma
50. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
51. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice
52. Long-term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides
53. Lymphokine and cytokine production by FceRI+ Cells
54. Innate immunity: Impact on the adaptive immune response
55. Innate immunity: The virtues of a nonclonal system of recognition
56. Maturation, activation and protection of dendritic cells induced by double stranded RNA
57. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS
58. Minimal requirements for murine resistance to infection with Francisella tularensis LVS
59. Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria
60. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine Leishmaniasis
61. Reciprocal expression of IFNgamma or IL-4 during the resolution or progression of murine leishmaniasis
62. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge
63. Rapid immune activation by CpG motifs in bacterial DNA
64. Macrophages ingest and are activated by bacterial DNA
65. Oligodeoxyribonucleotides with 5'-ACGT-3' or 5'TCGA-3' sequence indace production of interferons
66. Activation of human B cells by phosphorothioate oligodeoxynucleotides
67. Consequences of bacterial CpG DNA-driven activation of antigen presenting cells
68. CpG Oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg induced pathology by an IL-12 independent mechanism